NDC 31722-158 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate

Amphetamine Aspartate Monohydrate 3.125 mg/1; Amphetamine Sulfate 3.125 mg/1; Dextroamphetamine Sulfate 3.125 mg/1; Dextroamphetamine Saccharate 3.125 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC31722-158

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate
Generic name
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213709
Marketed since
May 10, 2021
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
31722-158-01100 TABLET in 1 BOTTLE (31722-158-01)May 10, 2021

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products